knowledge -WSS

knowledge

author：knowledge 2025-09-06 03:39:44 - browse：67

Business standing in the middle of a maze near a bag with a dollar sign on it. -- biotech coverage from STAT — Adobe

Over the last year or two, something curious has started occurring in the conference rooms and private Zoom meetings of biotech venture capitalists.

Representatives from pension funds, college endowments, family offices, and other organizations with money to invest have become bolder in their requests, according to interviews with a host of VCs. They’re pushing not only for advantageous terms in a VC firm’s latest fund, but in some cases, have angled for equity in the firm itself. These types of conditions aren’t unheard of, but have become more frequent as venture capitalists have a harder time raising funds, and as outside investors feel empowered to ask for more bang for their buck.

“A lot is changing in venture fundraising right now,” said Nan Li, co-founder and managing partner of Dimension, which launched last January. Outside investors tried to ask for a piece of Dimension, but the new firm had more than enough interest in its first fund and was able to turn down those proposals. Two other young VC firms told STAT they’ve fielded similar requests, and one investment group reported that it had managed to negotiate an equity stake in a VC firm.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Dobbs anniversary: the lost opportunity of abortion as health care
Next article： What to watch for from Zogenix and Amicus clinical trials

knowledge

WSS

Device maker Teleflex to acquire urology company for $600M

How doctors’ personal politics affect patients

China sends large group of warplanes, navy ships towards Taiwan in forceful display

US economic growth accelerated in 2nd quarter, exceeding expectations and quieting recession fears

Russia's threat to pull out of Ukraine grain deal raises fears about global food security

Why patients can’t get everything they want on drug pricing

Wikipedia

knowledge

knowledge

How to save PrEP access — and even expand it

How are insurers handling Leqembi and related scans?

The cancer drug shortage isn’t new — and neither are the solutions

Blinken talks high

Medical records are filled with copy

One Duchenne patient's bittersweet hope for new treatment

Bright Health sells Medicare Advantage business to Molina

Device maker Teleflex to acquire urology company for $600M

Trump demands the U.S. pay no more for drugs than other countries … again

The debate over Covid

explore

Digital health funding stays low as a new reality sets in

The debate over Covid

Kerry to visit Beijing for climate talks amid efforts to revive relations between US and China

The battle over 'scope creep' and who gets to be called 'doctor'

Roche’s Alnylam deal shows drug firms interested in heart drugs

Is there an 'orca uprising'? Like orcas themselves, the answer is complex.

focus

leisure time

focus

Wikipedia